Eagle Pharmaceuticals, Inc. (EGRX) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$2.36
Day's range
$3

Eagle Pharmaceuticals, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
STANLEY-LAMAN GROUP, LTD. 04/16/2025 12.00 K $11.76 K   0.00% 0.09%
ARCHER INVESTMENT CORP 05/05/2025 350 $343   0.00% 0.00%
BARCLAYS PLC 05/15/2025 0 $0   -100.00% 0.00%
ACADIAN ASSET MANAGEMENT LLC 05/21/2025 0 $0   -100.00% 0.00%
CREDIT AGRICOLE S A 05/14/2025 0 $0   -100.00% 0.00%
SIMPLEX TRADING, LLC 05/12/2025 0 $0   -100.00% 0.00%
ADVISOR GROUP HOLDINGS, INC. 05/12/2025 0 $0   -100.00% 0.00%
RUSSELL INVESTMENTS GROUP, LTD. 05/13/2025 0 $0   -100.00% 0.00%
XTX TOPCO LTD 05/08/2025 0 $0   -100.00% 0.00%
FARTHER FINANCE ADVISORS, LLC 04/14/2025 0 $0   -100.00% 0.00%

Eagle Pharmaceuticals, Inc. institutional Ownership - FAQ's

During the previous two years, 77 institutional investors and hedge funds held shares of Eagle Pharmaceuticals, Inc.. The most heavily invested institutionals were:

Stanley-Laman Group, Ltd.: 12,000

Archer Investment Corp: 350

ACADIAN ASSET MANAGEMENT LLC: 0

BARCLAYS PLC: 0

Russell Investments Group, Ltd.: 0

SIMPLEX TRADING, LLC: 0

0.09% of Eagle Pharmaceuticals, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 3.52 M shares in the last 24 months. This purchase volume represents approximately $10.56 M in transactions.